Humacyte Ownership | Who Owns Humacyte?
Humacyte Ownership Summary
Humacyte is owned by 19.35% institutional investors, 16.70% insiders, and 63.95% retail investors. Blackrock is the largest institutional shareholder, holding 6.60% of HUMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.42% of its assets in Humacyte shares.
HUMA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Humacyte | 19.35% | 16.70% | 63.95% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 7.14M | 6.60% | $34.27M |
| Blackrock funding, inc. /de | 9.90M | 6.37% | $17.23M |
| Vanguard group | 7.52M | 4.84% | $13.08M |
| Geode capital management | 3.10M | 1.99% | $5.39M |
| State street | 2.41M | 1.55% | $4.19M |
| Morgan stanley | 2.10M | 1.35% | $3.65M |
| Ubs group | 2.00M | 1.29% | $3.48M |
| Woodline partners lp | 2.00M | 1.29% | $3.48M |
| Two sigma investments, lp | 1.37M | 0.88% | $2.38M |
| Millennium management | 918.85K | 0.77% | $4.64M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lion point capital, lp | 83.50K | 0.83% | $145.29K |
| Wealth effects | 208.02K | 0.12% | $361.95K |
| Imprint wealth | 18.91K | 0.11% | $32.90K |
| Lji wealth management | 316.00K | 0.10% | $549.84K |
| Endowment wealth management | 109.46K | 0.09% | $190.46K |
| Clarus wealth advisors | 39.97K | 0.04% | $83.94K |
| United asset strategies | 184.61K | 0.03% | $321.22K |
| Centerbook partners lp | 283.63K | 0.02% | $493.51K |
| Hamilton lane advisors | 21.89K | 0.02% | $38.09K |
| Lasalle st. investment advisors | 67.32K | 0.02% | $117.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 7.14M | 0.00% | 2.35M |
| Morgan stanley | 2.10M | 0.00% | 720.16K |
| Vanguard group | 7.52M | 0.00% | 520.43K |
| Royal bank of canada | 497.00K | 0.00% | 400.37K |
| Susquehanna group, llp | 783.08K | 0.00% | 226.11K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Heights capital management | - | - | -4.03M |
| Ra capital management | - | - | -3.31M |
| Centerbook partners lp | 283.63K | 0.02% | -3.15M |
| Aigh capital management | - | - | -2.16M |
| Toronto dominion bank | - | - | -2.13M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Integrated advisors network | 86.78K | 0.01% | 86.78K | $151.00K |
| Creative planning | 44.01K | 0.00% | 44.01K | $76.58K |
| Wolverine trading | 22.14K | - | 22.14K | $38.31K |
| Imprint wealth | 18.91K | 0.11% | 18.91K | $32.90K |
| Gts securities | 17.40K | 0.00% | 17.40K | $83.52K |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -7.00 |
| Org partners | -10.00 |
| Principal securities | -15.00 |
| Transce3nd | -16.00 |
| Gen-wealth partners | -85.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 91 | -41.67% | 30,080,405 | -43.82% | 19 | 1.63% | 36 | -64.36% | 27 | 12.50% |
| Jun 30, 2025 | 163 | -6.86% | 56,940,940 | -6.40% | 36 | 1.71% | 104 | 8.33% | 26 | -29.73% |
| Mar 31, 2025 | 176 | 2.92% | 61,024,544 | 45.00% | 46 | 3.74% | 97 | - | 37 | -7.50% |
| Dec 31, 2024 | 87 | -42.38% | 22,175,982 | -38.04% | 18 | 2.07% | 52 | -41.57% | 18 | -30.77% |
| Sep 30, 2024 | 149 | 14.62% | 35,789,080 | 14.71% | 29 | 3.61% | 90 | -8.16% | 25 | 78.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.78M | 2.42% | -33.25K |
| iShares Russell 2000 ETF | 2.99M | 1.89% | - |
| SPDR® S&P Biotech ETF | 2.26M | 1.43% | 5.04K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.28M | 0.82% | -561.50K |
| Fidelity Small Cap Index | 1.26M | 0.79% | 337.22K |
| Nuveen Quant Small Cap Equity R6 | 728.27K | 0.61% | - |
| iShares Russell 2000 Value ETF | 832.82K | 0.53% | - |
| iShares Biotechnology ETF | 742.68K | 0.47% | - |
| MEDICAL BioHealth EUR Acc | 718.45K | 0.45% | - |
| Fidelity Extended Market Index | 622.28K | 0.39% | -4.60K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 18, 2025 | Dougan Brady W | - | Sell | $1.01M |
| Aug 20, 2025 | Dougan Brady W | - | Sell | $934.86K |
| Aug 19, 2025 | Dougan Brady W | - | Sell | $1.79M |
| Aug 19, 2025 | Niklason Laura E | President, CEO and Director | Sell | $1.79M |
| Aug 18, 2025 | Niklason Laura E | President, CEO and Director | Sell | $1.01M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | 6 |
| 2025 Q2 | 6 | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 3 | 6 |
HUMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools